A DNA signature to identify high-risk small node-negative breast cancer patients

被引:1
|
作者
Gravier, E. [1 ,2 ,3 ,4 ]
Pierron, G. [1 ,5 ]
Vincent-Salomon, A. [5 ,6 ]
Gruel, N. [6 ]
Raynal, V. [6 ]
Savignoni, A. [2 ]
De Rycke, Y. [2 ]
Pierga, J. P. [7 ]
Lucchesi, C. [6 ]
Reyal, F. [8 ]
Fourquet, A. [9 ]
Roman-Roman, S. [1 ]
Radvanyi, F. [10 ]
Sastre-Garaus, X. [5 ]
Asselain, B. [2 ,3 ,4 ]
Delattre, O. [6 ]
机构
[1] Inst Curie, Dept Translat Res, Paris, France
[2] Inst Curie, Dept Biostat, Paris, France
[3] INSERM, U900, F-75654 Paris 13, France
[4] Ecole Mines Paris, Fontainebleau, France
[5] Inst Curie, Dept Tumor Biol, Paris, France
[6] Inst Curie, INSERM, U830, Paris, France
[7] Univ Paris 05, Inst Curie, Dept Med Oncol, Paris, France
[8] Inst Curie, Dept Surg Oncol, Paris, France
[9] Inst Curie, Dept Radiat Oncol, Paris, France
[10] CNRSIIC, UMR 144, Paris, France
来源
EJC SUPPLEMENTS | 2010年 / 8卷 / 03期
关键词
D O I
10.1016/S1359-6349(10)70214-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:111 / 112
页数:2
相关论文
共 50 条
  • [1] Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer.
    Martin, Miguel
    Segui, Miguel A.
    Anton, Antonio
    Ruiz, Amparo
    Ramos, Manuel
    Adrover, Encarna
    Aranda, Ignacio
    Rodriguez-Lescure, Alvaro
    Grosse, Regina
    Calvo, Lourdes
    Barnadas, Agusti
    Isla, Dolores
    Martinez del Prado, Purificacion
    Ruiz Borrego, Manuel
    Zaluski, Jerzy
    Arcusa, Angels
    Munoz, Montserrat
    Lopez Vega, Jose M.
    Mel, Jose R.
    Munarriz, Blanca
    Llorca, Cristina
    Jara, Carlos
    Alba, Emilio
    Florian, Jesus
    Li, Junfang
    Lopez Garcia-Asenjo, Jose A.
    Saez, Amparo
    Jose Rios, Maria
    Almenar, Sergio
    Peiro, Gloria
    Lluch, Ana
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (23): : 2200 - 2210
  • [2] Utilization of neoadjuvant chemotherapy in high-risk, node-negative early breast cancer
    Prakash, Ipshita
    Ben Neely, N.
    Thomas, Samantha M.
    Sammons, Sarah
    Blitzblau, Rachel C.
    DiLalla, Gayle A.
    Hyslop, Terry
    Menendez, Carolyn S.
    Plichta, Jennifer K.
    Rosenberger, Laura H.
    Fayanju, Oluwadamilola M.
    Hwang, E. Shelley
    Greenup, Rachel A.
    [J]. CANCER MEDICINE, 2022, 11 (04): : 1099 - 1108
  • [3] Recurrence risk in small, node-negative, early breast cancer
    Nagaoka, R.
    Horiguchi, J.
    Takata, D.
    Sato, A.
    Tokiniwa, H.
    Higuchi, T.
    Uchida, S.
    Tsuboi, M.
    Kikuchi, M.
    Takeyoshi, I.
    [J]. BREAST, 2015, 24 : S118 - S119
  • [4] Outcomes in patients with small node-negative invasive breast cancer
    Bao, Jean
    Donovan, Cory
    Amersi, Farin
    Zhang, Xiao
    Giuliano, Armando E.
    Chung, Alice
    [J]. BREAST JOURNAL, 2019, 25 (04): : 638 - 643
  • [5] Outcomes in Patients With Small Node-Negative Invasive Breast Cancer
    Bao, Jean
    Donovan, Cory
    Amersi, Farin
    Zhang, Xiao
    Giuliano, Armando
    Chung, Alice
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : 35 - 36
  • [6] A Prognostic DNA Signature for T1T2 Node-Negative Breast Cancer Patients
    Gravier, Eleonore
    Pierron, Gaelle
    Vincent-Salomon, Anne
    Gruel, Nadege
    Raynal, Virginie
    Savignoni, Alexia
    De Rycke, Yann
    Pierga, Jean-Yves
    Lucchesi, Carlo
    Reyal, Fabien
    Fourquet, Alain
    Roman-Roman, Sergio
    Radvanyi, Francois
    Sastre-Garau, Xavier
    Asselain, Bernard
    Delattre, Olivier
    [J]. GENES CHROMOSOMES & CANCER, 2010, 49 (12): : 1125 - 1134
  • [7] EFFICACY OF ADJUVANT CHEMOTHERAPY IN HIGH-RISK NODE-NEGATIVE BREAST-CANCER - AN INTERGROUP STUDY
    MANSOUR, EG
    GRAY, R
    SHATILA, AH
    OSBORNE, CK
    TORMEY, DC
    GILCHRIST, KW
    COOPER, MR
    FALKSON, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08): : 485 - 490
  • [8] A Prognostic Assay to Identify Patients at High Risk of Mortality Despite Small, Node-Negative Lung Tumors
    Kratz, Johannes R.
    Van den Eeden, Stephen K.
    He, Jianxing
    Jablons, David M.
    Mann, Michael J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (16): : 1629 - 1631
  • [9] Are there patients with T1-T2, node-negative breast cancer who are high-risk for locoregional recurrence?
    Mamtani, A.
    Patil, S.
    Stempel, M.
    Morrow, M.
    [J]. CANCER RESEARCH, 2017, 77
  • [10] RAPID GROWTH-RATE - A METHOD OF IDENTIFYING NODE-NEGATIVE BREAST-CANCER PATIENTS WITH A HIGH-RISK OF RECURRENCE
    CHARLSON, ME
    FEINSTEIN, AR
    [J]. JOURNAL OF CHRONIC DISEASES, 1983, 36 (12): : 847 - 853